SCHEMBL11632016

SCHEMBL11632016

Nc1ccc(C(=O)CCC(=O)O)cc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
NR4A2 P43354 1/20 0.50
PKM P14618 1/20 0.49
TSHR P16473 1/20 0.49
CYP1A2 P05177 3/20 0.49
RAB9A P51151 2/20 0.49
FFAR1 O14842 1/20 0.49
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HIF1A Q16665 1/20 0.49
ALDH1A1 P00352 3/20 0.47
CYP2C19 P33261 2/20 0.47
HSD17B10 Q99714 2/20 0.47
HPGD P15428 1/20 0.47
USP5 P45974 1/20 0.46
GAA P10253 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
MMP2 P08253 1/20 0.42
MMP12 P39900 1/20 0.42
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3148795 0.85 NR4A2 (0.53) KMT2ANR4A2PKMTSHRCYP1A2
SCHEMBL9365461 0.83 GAA (0.57) KMT2ANR4A2PKMTSHRCYP1A2
SCHEMBL30309808 0.83 GAA (0.57) KMT2ANR4A2PKMTSHRCYP1A2
SCHEMBL14757822 0.82 HSD17B3 (0.56) KMT2ATSHRRAB9ASMN1; SMN2ALDH1A1
SCHEMBL10708232 0.81 ALDH1A1 (0.50) KMT2ANR4A2PKMTSHRCYP1A2
SCHEMBL10764064 0.81 KMT2A (0.58) KMT2ANR4A2PKMTSHRCYP1A2
SCHEMBL27749561 0.79 MAPT (0.45) KMT2ARAB9ALMNAALDH1A1HSD17B10
SCHEMBL28322888 0.79 KMT2A (0.47) KMT2ANR4A2PKMTSHRCYP1A2
SCHEMBL11632317 0.79 KMT2A (0.50) KMT2ANR4A2PKMTSHRCYP1A2
SCHEMBL11631620 0.79 KMT2A (0.59) KMT2ANR4A2PKMTSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4082843-A 3-(3-(3-Substituted amino-2-hydroxypropoxy)phenyl)-6-hydrazino pyridazines and their use as vasodilators and β-adrenergic blocking agents SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1978-04-04 US disclosed